THE REPORTED INHIBITION OF DCA-SALT HYPERTENSION BY ANTIHISTAMINIC DRUGS: EFFECTS OF SANDOSTENE, PHENERGAN AND CHLORPROMAZINE1

MLA

R. C. Nairn, et al. “The Reported Inhibition of Dca-Salt Hypertension by Antihistaminic Drugs: Effects of Sandostene, Phenergan and Chlorpromazine1.” Endocrinology, vol. 57, Dec. 1955, pp. 670–75. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........167145ca4b9eb651bc4a6976fe052bf7&authtype=sso&custid=ns315887.

APA

R. C. Nairn, Georges M. C. Masson, & A. C. Corcoran. (1955). The Reported Inhibition of Dca-Salt Hypertension by Antihistaminic Drugs: Effects of Sandostene, Phenergan and Chlorpromazine1. Endocrinology, 57, 670–675.

Chicago

R. C. Nairn, Georges M. C. Masson, and A. C. Corcoran. 1955. “The Reported Inhibition of Dca-Salt Hypertension by Antihistaminic Drugs: Effects of Sandostene, Phenergan and Chlorpromazine1.” Endocrinology 57 (December): 670–75. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........167145ca4b9eb651bc4a6976fe052bf7&authtype=sso&custid=ns315887.